CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CASCADE aims to advance the production of mesenchymal stem cells for regenerative medicine, focusing on their application in treating skin and corneal wounds. The project emphasizes good manufacturing practices and the development of innovative technologies to ensure quality and safety in cell therapies.
Rapid progress in stem cell research pave the way for the development and use of new cell therapy products in regenerative medicine.
The objective of CASCADE is to provide the European Community with unique expertise which focuses on the GMP production of mesenchymal stem cells (MSC) and their use in treating skin and corneal wounds, so that quality and safety criteria are paramount and match therapeutic expectations.
Commencing with known procedures, CASCADE will develop innovative technologies…
ETABLISSEMENT FRANCAIS DU SANG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO
Italy, Milano
Type: Other
Activity type: Other
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
